Article
RAS Pathway Mutations and Therapeutics in Vascular Anomalies.
Pediatric blood & cancer - 1 May 2025
Alharbi Sara, Merkle Svatava, Hammill Adrienne M, Waters Andrew M, Le Cras Timothy D
Abstract excerpt
Vascular anomalies (VAs) are a diverse group of vascular tumors and vascular malformations (VMs). VMs are characterized by abnormal vessel development, overgrowth, and dysfunction. Coagulopathy, edema, and effusions can cause severe morbidity and mortality in children and adults with these diseases. Germline or somatic mutations in the RAS/RAF/MAPK pathway have been identified in multiple types of VAs. RAS genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
